Loading company…
Niuruite Medical, based in Chengdu, makes radiopharmaceuticals and medical isotopes used to diagnose and treat malignant tumors.
Founded in 2016 in Chengdu, China, Niuruite Medical develops radiopharmaceuticals and medical isotopes for diagnosing and treating malignant tumors, including Ge-68 and Ac-225. It sells these products to hospitals, research institutes and pharmaceutical companies. In April 2026 it raised CNY 1 billion in Series E funding co-led by Shanghai STVC Group, Shanghai Guoxin Venture Capital Investment and Neovision Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in